Patient Selection for Immunotherapy in NSCLC – OncLive
OncLive |
Patient Selection for Immunotherapy in NSCLC
OncLive Marina Chiara Garassino, MD: The PACIFIC trial is a fundamental trial for the treatment of locally advanced non–small cell lung cancer. Because we have to think that for the past 20 years, we had nothing because we had to just get treatment strategies … |
